To amend title XVIII of the Social Security Act to require Medicare Advantage plans and part D prescription drug plans to include information on the risks associated with opioids, coverage of certain nonopioid treatments used to treat pain, and on the safe disposal of prescription drugs, and for other purposes.
Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018
(Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).
(Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs.
(Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.
Read twice and referred to the Committee on Finance.
Placed on the Union Calendar, Calendar No. 575.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Became Public Law No: 115-271.
Introduced in House
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Referred to the Subcommittee on Health.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
Committee on Energy and Commerce discharged.
Committee on Energy and Commerce discharged.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
Placed on the Union Calendar, Calendar No. 594.
Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5256-5258)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.